| Title： | Expert consensus on prevention and treatment of SiSe disease (rheumatoid arthritis) by Yi medicine |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | This specification is applicable to guide the medical personnel of Yi medicine, traditional Chinese medicine, traditional Chinese medicine and integrated Chinese and Western medicine in ethnic medicine hospitals, Chinese medicine hospitals, integrated Chinese and Western medicine hospitals, general hospitals and grassroots hospitals, etc., to refer to this Consensus in their clinical practice and to provide patients with rheumatoid arthritis with a more comprehensive and individualized treatment plan. |
| Evidence classification method： | Evidence search combined with expert consensus |
| Development unit： | Yunnan province hospital of traditional Chinese medicine (yunnan university first affiliated hospital of traditional Chinese medicine), Chuxiong Yi autonomous prefecture of traditional Chinese medicine hospital, Liangshan Hospital of integrated Traditional and Westem Medicine |
| Registration time: | 2024-10-07 |
| Registration number： | PREPARE-2024CN728 |
| Purpose of the guideline: | Yi medicine offers distinctive advantages and clinical efficacy in the prevention and treatment of sarcoidosis (rheumatoid arthritis). However, there is currently no standardized expert consensus on Yi medicine for sarcoidosis (rheumatoid arthritis). This expert consensus aims to fully leverage the distinctive advantages of Yi medicine, standardize the clinical practice of Yi medicine in the prevention and treatment of rheumatoid arthritis, guide physicians in clinical decision-making, and enhance the influence and recognition of Yi medicine. |
Latest registration
